Tehran University of Medical Sciences
Office of Vice-Chancellor for Global Strategies & International Affairs
International Human Capacity Development (IHCD)
Code : 9345-354127      Publish Date : Wednesday, March 7, 2018 Visit : 1959

Intl. Congress form | International Congress Report | International Congress Report For Faculty | The report of ESMO 2017 Congress by Dr. Hamideh Salimzadeh

The report of ESMO 2017 Congress by Dr. Hamideh Salimzadeh
The report of ESMO 2017 Congress by Dr. Hamideh Salimzadeh
Application Code :
762-0217-0055
 
Created Date : Monday, September 18, 2017-11:01 11:01:26Update Date : Thursday, February 1, 2018-09:28 09:28:57
IP Address : 194.225.213.77Submit Date : Thursday, February 1, 2018-09:29 09:29:37Email :salimzadeh.h@gmail.com
Personal Information
Name : Hamideh
Surname : Salim Zadeh Hossein Abad
School/Research center : other
If you choose other, please name your Research center : Digestive Diseases Research Institute
Position : Assistant professor
Tel : +98-21-82415492
Information of Congress
Title of the Congress : ESMO 2017 Congress
Title of your Abstract : Colon Cancer Screening by Fecal Immunochemical Testing in Iran
Destination Country : Spain
From : Friday, September 8, 2017
To : Tuesday, September 12, 2017
Abstract(Please copy/paste the abstract send to the congress) : Abstract Background: Colorectal cancer (CRC) is the third-most common cancer in Iran, whereas there is no mass screening for the disease yet. We aimed to measure the uptake and feasibility of a pilot colorectal screening programme based on fecal immunochemical test (FIT) in population aged between 45 and 75 years and the implications for scaling-up at the national level. Methods: This pilot study was conducted in Tehran and individuals aged between 45 and 75 years in rural and urban areas were enrolled in the screening programme. The FIT was offered by health navigators in primary health centers by collecting one single sample directly in to buffer kits by each participant. Health navigators aimed at increasing uptake and handled the whole screening programme from invitation to the referrals and provided the participants with information regarding the nature and importance of the CRC screening and details as to how to collect stool samples and send them back to the laboratory for analysis. If the first kit was not returned within 48 hours, a reminder call was sent. The test was developed within 7 days in an accredited laboratory designated to the study. Those participants who had a positive FIT were referred to undergo a colonoscopy. Results: A total number of 1044 asymptomatic average-risk individuals were enrolled. The age mean (SD) was 54.1± 7.0 and nearly 63.0% (n=657) were female. Only small fraction of the participants had awareness about colon cancer (13.7%) or polyps (8.3%) or screening tests (9.2%). Likewise their prior screening practice was extremely weak (2.2%). In multivariate regression analysis, awareness about colon cancer and screening tests significantly varied according to the ethnic groups, years of schooling, and family history of cancers (P <0.05). In sum, 1002 returned the FIT kit, of which stool sample in six participants (0.6%) was deemed unsatisfactory for testing. The FIT uptake was 96.0%, the positivity rate was 9.1% and the detection rates were 11.9% for adenomas and 7.1% for advanced adenomas. No cancer was detected. Conclusions: This is the first study that reports minimal quality metrics within a CRC screening process for the pilot phase before expanding into a national program. Based on our results, FIT modality as a test of choice for colon cancer screening in average-risk asymptomatic people is a safe and highly acceptable method of screening. Therefore, we suggest consideration of FIT as an initial CRC screening tool along with other preventive services in primary health care system in the nation. The results of the current study may not be limited to Iranians, and could have implications to other developing countries with similar trends of CRC epidemic.
Keywords of your Abstract : Population screening, colorectal cancer, feasibility studies, patient navigation
Acceptance Letter : http://gsia.tums.ac.ir/images/UserFiles/22927/Forms/762/ESMO_2017__accept.pdf
The presentation : Poster
The Cover of Abstract book : http://gsia.tums.ac.ir/images/UserFiles/22927/Forms/762/booklet-cover.pdf
Published abstract in the abstract book with the related code : http://gsia.tums.ac.ir/images/UserFiles/22927/Forms/762/ESMO2017-SPAIN.pdf
Where has your abstract been indexed? : ISI
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : 23000
Delegates from which countries presented in the congress? : Throughout the world eg, USA, Canada,Europe: Norway, England,Denmark, Netherlands, Sweden, Italy,...; Asia:...China, Japan,...
Were the delegates of any other organizations present in the congress? : Yes
If yes, please write the names of the organizations in the box : ASCO, EACR, AACR, ...
What were the responses to your talking points? Were specific questions or concerns raised? : In general the response to my poster presentation was good and some questions raised with regard to the methodology, which were responded by me while presenting my poster.
If you met staff members, please list their full names & positions. : I did not meet any specific staff member in the congress. But I renewed my membership of ESMO and EACR with the help of the organizations staff.
Please inform us if there are any follow up actions we need to talk with the members of the congress : Thanks, no fallow up actions are needed.
Your experiences about the travel processes(Providing ticket, accommodation,...) : All these was managed by myself and I paid for them myself. I think travel costs better be paid by the university in advance. Unfortunately university payment happens ages after the congress, and this is not good. Also accommodation was very expensive and the university dose not support for these costs.
Please give a briefing of your own observations and outcomes of the congress: : It was a very well organized congress. All sessions particularly those with regard to cancer prevention& control, cancer screening, patient advocacy, palliative care were very useful given much relevancy to my expertise and work. Also, I presented my poster on 10th Sept and was available for Q&A during poster visit time. I plan to make efforts for the translation of the knowledge learnt from the congress into our health care system by implementing colon cancer screening.